Omega Diagnostics reports positive results for COVID-19 test
A look at the major movers on the London market on Wednesday
2.51pm: Healthcare group reports positive test results
Omega Diagnostics Group PLC (LON:ODX) is in demand after announcing postive results for the Mologic COVID-19 lateral flow antigen test.
The test, which Omega has launched for professional use under its Visitect brand, has been independently verified in a 665-person study in Germany by FIND, a World Heath Organisation collaborating centre.
Omega said the test was shown to demonstrate best-in-class performance with 100% specificity and 96.4% sensitivity compared with laboratory testing.
Chief executive Colin King said: "This is great news for the Mologic test, which we are now producing under our Visitect brand. It is significant that the test has been shown to have high diagnostic accuracy on self-collected swab specimens. Rapid diagnostic tests play a crucial role in breaking the spread of infection in the community and we are delighted to be a leading manufacturer of these home-grown tests."